Protecadin OD tablets 10 mg for gastritis and ulcer (Lafutidine, Stogar, Lafaxin)

What are Protecadin OD tablets 10 mg for gastritis and ulcer (Lafutidine Stogar, Lafaxin)?

An active principle of Protecadin OD tablets is lafutidine, a second-generation antagonist of the histamine H2 receptors. This medication is primarily designed to address issues related to stomach acid secretion and associated gastric mucosal problems. Lafutidine functions by blocking histamine H2 receptors present in the gastric mucosa, effectively reducing the production of stomach acid.

In addition to its acid-suppressing properties, Protecadin OD tablets promote the production of gastric mucus and enhance gastric mucosal blood flow, thereby safeguarding the stomach lining against potential inflammation-induced injuries. Moreover, these tablets inhibit the attachment of Helicobacter pylori, a bacterium commonly associated with gastric-related ailments, to gastric cells.

Protecadin OD tablets are effective for the treatment of gastric ulcers, duodenal ulcers, and anastomotic gastric ulcers. Furthermore, these tablets can be utilized for the management of reflux esophagitis and other lesions in the gastric mucosa, such as erosions and bleeding. Additionally, Protecadin OD tablets can assist in the treatment of acute gastritis and chronically exacerbated gastritis. They can also be employed as part of an anesthetic preparation.

Clinical studies have demonstrated the prolonged antisecretion and healing effects of lafutidine against gastric ulcers and duodenal ulcers. In fact, its potency has been found to be comparable to or even superior to that of conventional H2 antagonists commonly used for such conditions.

Active principles: lafutidine

Amount: 100 tablets

Maker: Taiho Pharmaceutical Co., Ltd., Tokyo, Japan

Indications:

• treatment of gastric, duodenal, or anastomotic gastric ulcers,
• treatment of reflux oesophagitis,
• treatment of gastric mucosal lesion (erosion, bleeding, etc.) caused by acute gastritis or acute exacerbation of chronic gastritis,
• as anesthesia premedication.

How to take

For the treatment of gastric/duodenal/anastomotic ulcer, reflux oesophagitis: adults should take 1 tablet (10 mg of the active principle) at a time, 2 times a day, after breakfast and after dinner or at bedtime. Your doctor may adjust the dose according to your age and symptoms.

For the treatment of gastric mucosal lesion caused by acute gastritis or acutely exacerbated chronic gastritis: adults should take 1 tablet once a day, after dinner or at bedtime. Your doctor may adjust the dose according to your age and symptoms.

For anesthetic premedication: adults should take 1 tablet at a time, 2 times; at bedtime of the day before the operation day, and 2 hours before anesthesia induction on the operation day.

Contraindications: do not use for pregnant or breastfeeding women. Do not use for patients with renal or liver impairment or patients receiving dialysis. 

Important information

This medicine dissolves on the tongue using saliva. You can take it with or without water.

If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.